Lyell Immunopharma Inc.

0.47
0.00 (1.08%)
At close: Apr 04, 2025, 1:05 PM

Lyell Immunopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
-342.99M -234.63M -183.12M -250.22M -204.47M -129.38M
19.63M 20.25M 18.02M 13.62M 4.29M 1.26M
33.14M 47.08M 81.92M 62.2M 33.26M 15.73M
114K 1.96M -82.68M 3.92M -58K 109.1M
130.94M 183K -6.68M 4.62M 11.99M 42.57M
n/a n/a 2.32M 39.51M -5.61M -1.52M
-3.12M 3.42M -82.02M 4.01M -336K 110.81M
-162.39M -163.69M -169.56M -126.25M -160.87M 39.47M
-464K -2.69M -24.28M -65.5M -51.48M -16.05M
n/a -186.73M -12.74M 673.47M n/a n/a
-394.71M -476.88M -406.32M -673.47M -43.45M -34M
548.94M 663.61M 419.05M 617.4M 686.32M 238.46M
-31.35M 186.73M 12.74M -673.47M -864.91M -610.84M
122.42M 184.05M -11.54M -121.57M -273.52M -422.43M
n/a n/a n/a n/a n/a n/a
36.01M -457K -461K n/a -16.05M -185K
n/a n/a n/a n/a n/a n/a
1.33M 1.74M 10.63M 9.44M 373K n/a
1.33M 1.74M 10.63M 401.24M 476.79M 351.16M
-38.64M 22.1M -170.46M 153.42M 42.4M -31.8M
-162.86M -166.38M -193.83M -191.75M -212.35M 23.43M